Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma

Abstract : A rat model of sarcomatoid mesothelioma, mimicking some of the worst clinical conditions encountered, was established to evaluate the therapeutic potential of intracavitary curcumin administration. The M5-T1 cell line, selected from a collection established from F344 rats induced with asbestos, produces tumors within three weeks, with extended metastasis in normal tissues, after intraperitoneal inoculation in syngeneic rats. The optimal concentration/time conditions for killing M5-T1 cells with curcumin were first determined in vitro. Secondly, the potential of intraperitoneal curcumin administration to kill tumor cells in vivo was evaluated in tumor-bearing rats, in comparison with a reference epigenetic drug, SAHA. Both agents administered at days 21 and 26 after tumor challenge produced necrosis within the solid tumors at day 28. However, tumor tissue necrosis induced with curcumin was much more extensive than with SAHA, and was characterized by infiltration with mononuclear phagocytic cells. In contrast, tumor tissue treated with SAHA contained foci of resistant cells and was infiltrated by many isolated CD8+ cells. The treatment of tumor-bearing rats with 1.5 mg/kg curcumin on days 7, 9, 11 and 14 after tumor challenge dramatically reduced the mean total tumor mass at day 16. Clusters of CD8+ T lymphocytes were observed at the periphery of small residual tumor masses in the peritoneal cavity, which presented a significant reduction in mitotic index, IL6 and vimentin expression compared with tumors in untreated rats. These data open up interesting new prospects for the therapy of sarcomatoid mesothelioma with curcumin and its derivatives.
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2017, [Epub ahead of print]. 〈10.18632/oncotarget.15744〉
Liste complète des métadonnées

Littérature citée [70 références]  Voir  Masquer  Télécharger

Contributeur : Elizabeth Bernardo <>
Soumis le : mercredi 1 mars 2017 - 12:03:50
Dernière modification le : vendredi 19 octobre 2018 - 10:02:01


 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier



Daniel Pouliquen, Béatrice Nawrocki-Raby, Joëlle Nader, Stéphanie Blandin, Myriam Robard, et al.. Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma. Oncotarget, Impact journals, 2017, [Epub ahead of print]. 〈10.18632/oncotarget.15744〉. 〈inserm-01480303〉



Consultations de la notice